Regulation of invasion of epithelial ovarian cancer by transforming growth factor-β

Gynecologic Oncology

Volumn 80, Issue 2, 2001, Pages 245-253

  Rodriguez, Gustavo C ^a   Haisley, Camille ^a   Hurteau, Jean ^b   Moser, Tammy L ^c   Whitaker, Regina ^a   Bast Jr , Robert C ^d   Stack, Mary Sharon ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Invasion; Metalloproteinase; Metastasis; Ovarian carcinoma; TGF

Indexed keywords

GI 12947; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL MOTILITY; COLORIMETRY; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; OVARY CANCER; PRIORITY JOURNAL;

EID: 0035135495     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6042     Document Type: Article

References (41)

1. Tumor cells with the basement membrane
2. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B
3. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line with a reconstituted basement membrane
4. Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro
5. Secretion of extracellular matrix-degrading proteinases is increased in ovarian epithelial carcinoma
6. Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epithelium
7. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: Purification of matrix metalloproteinase 2
8. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by α2β1-integrin-mediated interaction with type 1 collagen
9. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells
10. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase through β1 integrin
11. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy
12. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer: Relationship between receptor expression and response to epidermal growth factor
13. Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites
14. Regulation of tumor necrosis factor alpha by a metalloproteinase inhibitor
15. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide
16. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta
17. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma
18. Transforming growth factor-β stimulates mammary adenocarcinoma cell invasion and metastatic potential
19. Transforming growth factor beta 1 enhances the invasiveness of human MDA-MB-231 cells by up-regulating urokinase activity
20. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells
21. Effects of transforming growth factor-β on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro
22. Mechanisms of placental invasion of the uterus and their control
23. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor-β
24. Potentiation of invasive capacity of rat ascites hepatoma cells by transforming growth factor-β
25. 1 with tumor progression
26. Elevated levels of transforming growth factor beta 1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection
27. The effect of thrombospondin-1 and TGF-beta 1 on pancreatic cancer cell invasion
28. Enhanced expression of the type II transforming growth factor receptor is associated with decreased survival in human pancreatic cancer
29. Osteoblast-derived TGF-beta 1 modulates matrix degrading protease expression and activity in prostate cancer cells
30. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor beta 1 in human prostate cancer cell
31. Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype
32. Transforming growth factor-beta suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease
33. Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells
34. Ovarian carcinoma cultures are resistant to TGF-β1-mediated growth inhibition despite expression of functional receptors
35. Transforming growth factor beta in breast cancer: A working hypothesis
36. Transforming growth factor beta and cancer: A love-hate relationship?
37. TGF beta signaling is necessary for carcinoma cell invasiveness and metastasis
38. Cellular signaling in response to TGF beta: The paradox of a factor that blocks cell proliferation and enhances metastasis
39. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiognesis
40. The role of transforming growth factor beta in human cancer